Bortezomib in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer
Clinical trial NCT00023712 · COMPLETED
Trial details
- NCT number
- NCT00023712
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2001-11-05
- Primary completion
- 2010-01-01
- Enrollment
- 58
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.